S

STOK

Stoke Therapeutics

32.74

+0.75+2.34%
After Hours: 33.00  +0.26  +0.79%18:15 04/02 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Cash from Operating Activities

45.59M

-86.85M

-81.07M

-31.87M

-66.91M

Net Income

-6.88M

-88.98M

-104.70M

-101.07M

-85.81M

Depreciation/Depletion & Amortization

1.77M

2.18M

2.47M

1.55M

974.00K

Deferred Taxes

--

--

--

--

--

Non-Cash Items

34.35M

28.09M

27.19M

24.63M

17.88M

Changes in Working Capital

16.35M

-28.14M

-6.03M

43.02M

46.00K

Cash from Investing Activities

-186.81M

-107.47M

105.95M

-45.88M

-76.43M

Capital Expenditures

-670.00K

-203.00K

-1.62M

-3.96M

-1.20M

Other Investing Cash Flow Items, Total

-186.14M

-107.27M

107.56M

-41.92M

-75.23M

Cash from Financing Activities

97.39M

131.09M

53.01M

46.41M

1.28M

Financing Cash Flow Items

87.78M

8.96M

52.08M

45.34M

-2.00K

Total Cash Dividends Paid

--

--

--

--

--

Issuance (Retirement) of Stock, Net

9.61M

122.14M

926.00K

1.06M

1.29M

Issuance (Retirement) of Debt, Net

--

--

--

--

--

Foreign Exchange Effects

--

--

--

--

--

Net Change in Cash

-43.84M

-63.23M

77.89M

-31.34M

-142.05M

Cash Interest Paid

--

--

--

--

--

Cash Taxes Paid

--

--

--

--

--